Lebwohl David
Insider CIK 1810882 · NTLA EVP, Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-03-01 | 2026-03-03 | 14,204 | — | $0 | 14,204 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-03-01 | 2026-03-03 | 9,943 | — | $0 | 131,192 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-01-05 | 2026-01-07 | 11,903 | $9.21 | $109.6K | 121,249 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-03-01 | 2025-03-04 | 61,714 | — | $0 | 61,714 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-03-01 | 2025-03-04 | 43,200 | — | $0 | 130,866 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-01-03 | 2025-01-07 | 9,557 | $12.18 | $116.4K | 87,666 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2025-01-01 | 2025-01-03 | 3,189 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2025-01-01 | 2025-01-03 | 3,189 | — | $0 | 97,223 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-03-01 | 2024-03-05 | 55,855 | — | $0 | 55,855 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-03-01 | 2024-03-05 | 38,701 | — | $0 | 93,073 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-01-03 | 2024-01-05 | 5,843 | $29.46 | $172.1K | 54,372 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2024-01-01 | 2024-01-03 | 3,187 | — | $0 | 3,189 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2024-01-01 | 2024-01-03 | 3,187 | — | $0 | 60,215 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-03-01 | 2023-03-03 | 43,342 | — | $0 | 43,342 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-03-01 | 2023-03-03 | 30,674 | — | $0 | 56,361 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2023-01-04 | 2023-01-06 | 2,574 | $37.21 | $95.8K | 25,687 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2023-01-01 | 2023-01-04 | 3,187 | — | $0 | 6,376 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2023-01-01 | 2023-01-04 | 3,187 | — | $0 | 28,261 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 13,816 | — | $0 | 13,816 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-04 | 20,203 | — | $0 | 20,203 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-03-01 | 2022-03-03 | 13,816 | — | $0 | 24,738 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2022-01-01 | 2022-03-03 | 3,187 | — | $0 | 9,563 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2022-01-01 | 2022-03-03 | 3,187 | — | $0 | 11,973 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2022-01-01 | 2022-03-03 | 1,051 | $112.24 | $118.0K | 10,922 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-11-05 | 2021-11-09 | 2,400 | — | $0 | 180,077 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-11-05 | 2021-11-09 | 1,200 | $131.71 | $158.1K | 9,914 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-11-05 | 2021-11-09 | 2,400 | $12.62 | $30.3K | 11,114 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-11-05 | 2021-11-09 | 548 | $134.07 | $73.5K | 8,914 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-11-05 | 2021-11-09 | 200 | $135.34 | $27.1K | 8,714 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-11-05 | 2021-11-09 | 452 | $132.62 | $59.9K | 9,462 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-10-14 | 2021-10-15 | 2,400 | — | $0 | 182,477 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-10-14 | 2021-10-15 | 2,400 | $12.62 | $30.3K | 11,114 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-10-14 | 2021-10-15 | 849 | $127.81 | $108.5K | 9,714 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-10-14 | 2021-10-15 | 225 | $129.01 | $29.0K | 9,489 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-10-14 | 2021-10-15 | 525 | $129.83 | $68.2K | 8,964 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-10-14 | 2021-10-15 | 250 | $130.47 | $32.6K | 8,714 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-10-14 | 2021-10-15 | 551 | $126.92 | $69.9K | 10,563 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-09-24 | 2021-09-27 | 7,923 | — | $0 | 184,877 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-09-24 | 2021-09-27 | 7,923 | $12.62 | $100.0K | 8,714 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-09-21 | 2021-09-23 | 2,400 | — | $0 | 192,800 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-09-21 | 2021-09-23 | 2,400 | $12.62 | $30.3K | 3,191 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-09-21 | 2021-09-23 | 2,400 | $149.81 | $359.5K | 791 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-08-30 | 2021-09-01 | 2,400 | — | $0 | 195,200 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-08-30 | 2021-09-01 | 700 | $156.70 | $109.7K | 2,291 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-08-30 | 2021-09-01 | 1,100 | $159.19 | $175.1K | 941 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-08-30 | 2021-09-01 | 250 | $157.60 | $39.4K | 2,041 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-08-30 | 2021-09-01 | 150 | $160.10 | $24.0K | 791 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-08-30 | 2021-09-01 | 200 | $155.43 | $31.1K | 2,991 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-08-30 | 2021-09-01 | 2,400 | $12.62 | $30.3K | 3,191 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-08-09 | 2021-08-11 | 2,400 | — | $0 | 197,600 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-08-09 | 2021-08-11 | 2,400 | $164.05 | $393.7K | 791 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-08-09 | 2021-08-11 | 2,400 | $12.62 | $30.3K | 3,191 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-03-03 | 2021-03-05 | 12,750 | — | $0 | 12,750 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-03-03 | 2021-03-05 | 76,500 | — | $0 | 76,500 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-05-01 | 2020-05-05 | 200,000 | — | $0 | 200,000 | SEC↗ |